Serology and gene sequence analysis of rare subgroup A3 blood group
Blood&Genomics · 2022
DOI: 10.46701/bg.2022012022001 ↗Kurz gefasst
Fachartikel in der Zeitschrift Blood&Genomics, 2022. Verfasst von Guocai Li und 2 weiteren Autor:innen.
Abstract (Originalsprache)
To investigate the serological phenotypic characteristics and possible mechanism of subgroup A3, a blood donor's ABO phenotypes were detected by the conventional microcolumn gel method and classic tube method. N-acetylgalactosaminyl transferase activity was detected by the non-radioactive phosphate coupling method. ABO subtype genotyping was determined by PCR-SSP and exons 1-7 of ABO gene were analyzed by Sanger sequencing. The donor's blood type was subgroup A3 as evaluated by serological test. There was no N-acetylgalactosaminyl transferase activity in the red blood cells and weak N-acetylgalactosaminyl transferase activity in the plasma. The ABO blood group genotyping result was ABO*AO1, and the gene sequencing result was confirmed as A221/O01. Sequencing results showed two mutations, 467C>T and 607G>A in exon 7 in ABO*A allele. In conclusion, it is suggested that the ABO blood group of the donor be subgroup A3, which may be induced by mutations 467C>T and 607G>A, and led to a decrease in N-acetylgalactosaminyl transferase activity and resulted in weakened A antigen.
Zitieren
APA
Li, G., Li, F., & Liu, F. (2022). Serology and gene sequence analysis of rare subgroup A3 blood group. Blood&Genomics. https://doi.org/10.46701/bg.2022012022001
Vancouver
Li G, Li F, Liu F. Serology and gene sequence analysis of rare subgroup A3 blood group. Blood&Genomics. 2022. doi:10.46701/bg.2022012022001
BibTeX
@article{Li2022,
author = {Li, Guocai and Li, Fang and Liu, Fengxia},
title = {Serology and gene sequence analysis of rare subgroup A3 blood group},
journal = {Blood&Genomics},
year = {2022},
doi = {10.46701/bg.2022012022001}
}
EUVIMED